Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/2011 → 31/12/2017 |
Funding
- EC European Commission: £234,600.00
GENEGRAFT - Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with COL7A1-encoding SIN retroviral vector
- McGrath, John (Primary Investigator)
Project: Research